American researchers link oral bacteria to colon cancer progression
Researchers in America have established a link between a form of common oral bacteria and the acceleration of colon cancer.
A team from the College of Dental Medicine at Columbia University found that a common strain of oral bacteria, which is linked to tooth decay, can also contribute to colon cancer progression. F.nucleatum, which is often found in dental plaque, could play an instrumental role in the pace of colon cancer growth. Colon cancer is currently the second deadliest form of cancer in the US.
Yiping H Wan, study leader and professor of microbial sciences, explained that genetic mutations play a significant role in the development and spread of cancerous cells, but there are other factors to consider, including the presence of microbes. Scientists discovered that around a third of colon cancer cases are associated with the strain, and those were found to be more aggressive than others, but until now, it was not known why this was the case.
In a previous study, Han and his team discovered that the bacterium produced a molecule known as FadA adhesion, which was found to stimulate growth in cancerous cells, but not in healthy tissue. Prof Han wanted to build on the findings of that study and determine why F.nucleatum only triggered growth in cancerous cells. The most recent study focused on this interaction, and researchers found that non-cancerous cells lack a protein called Annexin A1, which stimulates growth. Using in-vitro trials, which were followed by trials involving mice, they determined that prohibiting Annexin 1 function prevented F.nucleatum from binding to cancerous cells. Subsequently, this slowed growth.
In light of their findings, Prof Han and the team are now looking for ways to use Annexin 1 as a biomarker for advanced, aggressive cancers and to utilise the study as a base for developing potential treatment options.